SiNON Therapeutics
Stage
Grant | AliveTotal Raised
$50KLast Raised
$50K | 7 yrs agoAbout SiNON Therapeutics
SiNON Therapeutics is dedicated to improving the lives of those who suffer from debilitating neurological diseases by increasing the ability of drugs to cross the Blood Brain Barrier (BBB). Their patented nanoparticle, the Carbon Dot, will enable pharmaceutical companies to encapsulate their drugs in a way, which dramatically improves drug-localization to the brain. This allows for a reduction in overall dose administration to the patient, leading to reduced toxicity and side effects, while improving therapeutic index and cost-efficacy. This unique platform technology can be applied to many different diseases such as Alzheimer's, Parkinsons, or brain tumors, just to name a few.
Loading...
Loading...
SiNON Therapeutics Patents
SiNON Therapeutics has filed 3 patents.
The 3 most popular patent topics include:
- fungal plant pathogens and diseases
- fungicides
- nitrates
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/28/2016 | 4/27/2021 | Molecular biology, Psychiatric diagnosis, Acetylcholinesterase inhibitors, Peripherally selective drugs, Biotechnology | Grant |
Application Date | 9/28/2016 |
|---|---|
Grant Date | 4/27/2021 |
Title | |
Related Topics | Molecular biology, Psychiatric diagnosis, Acetylcholinesterase inhibitors, Peripherally selective drugs, Biotechnology |
Status | Grant |
Latest SiNON Therapeutics News
Jun 1, 2017
Posted Jun. 1, 2017 at 6:56 a.m. SiNON Therapeutics advances in InnovateHER competition Published: 2017-06-01 06:56:52 Image 1 of 2 · Next Image… Related Blog Posts Tags: Startups , Venture & Innovation , Biotech & Life Science Raleigh, N.C. — The showdown at the Pink Ceiling on Wednesday night pitted six startups against each other in the opening round of the InnovateHER competition. And in a high-energy event before a packed house, SiNON Therapeutics earns the right to advance to the semifinal round. "The energy in the room tonight is emblematic of the seismic shift that is about to occur for female founded or focused companies," Cindy Whitehead, the CEO and founder of The Pink Ceiling, tells WRAL TechWire. The showcase took place at the Pinkubator, a hub for emerging startups launched by Whitehead in Raleigh's North Hills. SiNON founder Afreen Allam won the pitch event in the eyes of the event judges. SiNON Therapeutics has developed a novel method to cross the blood brain barrier, to treat a variety of diseases such as Alzheimer’s, brain tumors, etc SiNON recently received a $50,000 grant from the NC IDEA Foundation. The other "pitchers" included: NeuroVice, LLC - Developing the first oral device for epileptic patients. NeuroVice also will represent the Triangle in the 1776 Challenge Cup pitch competition. Elliegrid - The pill box with brains and beauty, lets you organize medications/vitamins in seconds, set reminders, track history, and know how loved ones are doing Thesis Couture- A SpaceX veteran that puts high tech in high heels by using science to make a comfortable high heel SuperVize - Wearable tech for kids that tracks their location to keep groups together Safe Movement - Privately show your verified STD [sexually transmitted disease] status on your phone The Small Business Administration (SBA) is offering $70,000 in cash prizes at the national event. WRAL TechWire any time: Twitter, Facebook Copyright 2017 WRAL TechWire. All rights reserved. The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…
SiNON Therapeutics Frequently Asked Questions (FAQ)
Where is SiNON Therapeutics's headquarters?
SiNON Therapeutics's headquarters is located at 2 Davis Drive, Durham.
What is SiNON Therapeutics's latest funding round?
SiNON Therapeutics's latest funding round is Grant.
How much did SiNON Therapeutics raise?
SiNON Therapeutics raised a total of $50K.
Who are the investors of SiNON Therapeutics?
Investors of SiNON Therapeutics include NC IDEA.
Loading...
Loading...